General MedicationsORALGeneric
CLOBAZAM
CLOBAZAM
Standard Dose
2.5MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CLOBAZAM is listed in Drugs@FDA under application 216008 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CLOBAZAM Form and strength SUSPENSION;ORAL - 2.5MG/ML Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2024-09-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview CLOBAZAM is listed in Drugs@FDA under application 216008 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CLOBAZAM Form and strength SUSPENSION;ORAL - 2.5MG/ML Sponsor ACCORD HLTHCARE Submission history Latest submission status date: 2024-09-16 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.